Neuhaus, O., Köhler, W., Then Bergh, F., Kristoferitsch, W., Faiss, J., Rosenkranz, T., . . . Zettl, U. K. (2021). Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers. Biomolecules.
Chicago-stil citatNeuhaus, Oliver, et al. "Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects On Self-Assessment Scales But Not On Molecular Markers." Biomolecules 2021.
MLA-referensNeuhaus, Oliver, et al. "Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects On Self-Assessment Scales But Not On Molecular Markers." Biomolecules 2021.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.